Display options
Cite
Laudanski K, Stentz M, DiMeglio M, et al. Potential Pitfalls of the Humanized Mice in Modeling Sepsis. Int J Inflam. 2018;2018:6563454doi: 10.1155/2018/6563454.
Laudanski, K., Stentz, M., DiMeglio, M., Furey, W., Steinberg, T., & Patel, A. (2018). Potential Pitfalls of the Humanized Mice in Modeling Sepsis. International journal of inflammation, 20186563454. https://doi.org/10.1155/2018/6563454
Laudanski, Krzysztof, et al. "Potential Pitfalls of the Humanized Mice in Modeling Sepsis." International journal of inflammation vol. 2018 (2018): 6563454. doi: https://doi.org/10.1155/2018/6563454
Laudanski K, Stentz M, DiMeglio M, Furey W, Steinberg T, Patel A. Potential Pitfalls of the Humanized Mice in Modeling Sepsis. Int J Inflam. 2018 Sep 02;2018:6563454. doi: 10.1155/2018/6563454. eCollection 2018. PMID: 30245803; PMCID: PMC6139216.
Copy Download .nbib Format: NLM
Share it on

Int J Inflam. 2018 Sep 02;2018:6563454. doi: 10.1155/2018/6563454. eCollection 2018.

Potential Pitfalls of the Humanized Mice in Modeling Sepsis.

International journal of inflammation

Krzysztof Laudanski, Michael Stentz, Matthew DiMeglio, William Furey, Toby Steinberg, Arpit Patel

Affiliations

  1. Department of Anesthesiology and Critical Care, University of Pennsylvania, Philadelphia, PA 19104, USA.
  2. Department of Anesthesiology and Intensive Care, Emory University, Atlanta, GA 30322, USA.
  3. Philadelphia College of Osteopathic Medicine, Philadelphia, PA 19131, USA.

PMID: 30245803 PMCID: PMC6139216 DOI: 10.1155/2018/6563454

Abstract

Humanized mice are a state-of-the-art tool used to study several diseases, helping to close the gap between mice and human immunology. This review focuses on the potential obstacles in the analysis of immune system performance between humans and humanized mice in the context of severe acute inflammation as seen in sepsis or other critical care illnesses. The extent to which the reconstituted human immune system in mice adequately compares to the performance of the human immune system in human hosts is still an evolving question. Although certain viral and protozoan infections can be replicated in humanized mice, whether a highly complex and dynamic systemic inflammation like sepsis can be accurately represented by current humanized mouse models in a clinically translatable manner is unclear. Humanized mice are xenotransplant animals in the most general terms. Several organs (e.g., bone marrow mesenchymal cells, endothelium) cannot interact with the grafted human leukocytes effectively due to species specificity. Also the interaction between mice gut flora and the human immune system may be paradoxical. Often, grafting is performed utilizing an identical batch of stem cells in highly inbred animals which fails to account for human heterogeneity. Limiting factors include the substantial cost and restricting supply of animals. Finally, humanized mice offer an opportunity to gain knowledge of human-like conditions, requiring careful data interpretation just as in nonhumanized animals.

References

  1. Infect Immun. 2016 Sep 19;84(10):3017-23 - PubMed
  2. Proc Natl Acad Sci U S A. 2010 Aug 31;107(35):15589-94 - PubMed
  3. J Immunol. 1997 Apr 15;158(8):3578-86 - PubMed
  4. Stem Cell Res Ther. 2015 Aug 14;6:142 - PubMed
  5. J Leukoc Biol. 2009 Aug;86(2):219-27 - PubMed
  6. Blood. 2017 Feb 23;129(8):959-969 - PubMed
  7. Science. 1992 Feb 28;255(5048):1137-41 - PubMed
  8. J Virol. 2009 Sep;83(17):8638-45 - PubMed
  9. J Immunol. 2017 Jul 15;199(2):383-388 - PubMed
  10. J Clin Invest. 2010 Jun;120(6):2218-29 - PubMed
  11. J Immunol. 2017 May 15;198(10):4129-4139 - PubMed
  12. Blood. 2013 Feb 21;121(8):1316-25 - PubMed
  13. J Leukoc Biol. 2008 Mar;83(3):536-45 - PubMed
  14. Blood. 2002 Nov 1;100(9):3175-82 - PubMed
  15. J Immunol. 2014 May 15;192(10):4636-47 - PubMed
  16. Blood. 2010 Jul 15;116(2):193-200 - PubMed
  17. J Immunol. 2010 Sep 1;185(5):2710-20 - PubMed
  18. Mol Ther. 2002 Sep;6(3):407-14 - PubMed
  19. Immunology. 2011 Dec;134(4):419-33 - PubMed
  20. Proc Natl Acad Sci U S A. 2013 Feb 26;110(9):3507-12 - PubMed
  21. Front Immunol. 2017 May 01;8:401 - PubMed
  22. Nat Immunol. 2007 Dec;8(12):1313-23 - PubMed
  23. Hum Immunol. 2010 Jun;71(6):551-9 - PubMed
  24. Int J Radiat Biol Relat Stud Phys Chem Med. 1988 May;53(5):709-16 - PubMed
  25. Front Immunol. 2018 Mar 05;9:344 - PubMed
  26. Toxicol Appl Pharmacol. 2017 Oct 15;333:17-25 - PubMed
  27. J Immunol Methods. 2014 Aug;410:18-27 - PubMed
  28. Biochem Pharmacol. 2014 Jan 1;87(1):162-71 - PubMed
  29. J Immunol. 2013 Sep 15;191(6):3192-9 - PubMed
  30. Cytometry A. 2016 Sep;89(9):803-15 - PubMed
  31. J Infect Dis. 2015 Aug 1;212(3):435-44 - PubMed
  32. Cytokine. 2015 May;73(1):91-100 - PubMed
  33. J Immunol. 2014 Feb 15;192(4):1982-9 - PubMed
  34. Am J Reprod Immunol. 2018 Jul;80(1):e12859 - PubMed
  35. Intensive Care Med. 2013 Feb;39(2):165-228 - PubMed
  36. Mucosal Immunol. 2012 Sep;5(5):555-66 - PubMed
  37. J Inflamm Res. 2015 Oct 16;8:201-9 - PubMed
  38. Immun Inflamm Dis. 2016 Aug 28;4(4):427-440 - PubMed
  39. J Immunol. 1995 Jan 1;154(1):180-91 - PubMed
  40. Int Immunol. 2009 Jul;21(7):843-58 - PubMed
  41. Retrovirology. 2011 Aug 11;8:65 - PubMed
  42. Biol Open. 2015 Sep 09;4(10):1243-52 - PubMed
  43. Hum Immunol. 2012 Apr;73(4):346-54 - PubMed
  44. Lancet Infect Dis. 2015 May;15(5):581-614 - PubMed
  45. J Virol. 2007 Dec;81(23):13259-64 - PubMed
  46. J Exp Med. 2012 Jul 30;209(8):1505-17 - PubMed
  47. Shock. 2003 Apr;19(4):310-3 - PubMed
  48. J Immunol. 2011 Oct 1;187(7):3895-903 - PubMed
  49. Vaccine. 2008 Jan 17;26(3):292-300 - PubMed
  50. J Immunol. 2000 Mar 1;164(5):2496-507 - PubMed
  51. Blood. 2011 Nov 24;118(22):5938-46 - PubMed
  52. J Allergy Clin Immunol. 2000 May;105(5):967-74 - PubMed
  53. Nat Biotechnol. 2014 Apr;32(4):364-72 - PubMed
  54. Blood. 2003 Nov 1;102(9):3302-10 - PubMed
  55. J Pharmacol Exp Ther. 2015 Jun;353(3):539-50 - PubMed
  56. Stem Cell Reports. 2015 Feb 10;4(2):171-80 - PubMed
  57. Stem Cells Dev. 2016 Apr 1;25(7):530-41 - PubMed
  58. Infect Immun. 2013 May;81(5):1520-31 - PubMed
  59. Proc Natl Acad Sci U S A. 2012 Dec 18;109(51):21052-7 - PubMed
  60. Nat Med. 2006 Nov;12(11):1316-22 - PubMed
  61. Int J Health Geogr. 2010 Feb 15;9:9 - PubMed
  62. Innate Immun. 2017 Apr;23(3):258-275 - PubMed
  63. Nature. 1983 Feb 10;301(5900):527-30 - PubMed
  64. Nature. 2013 Sep 12;501(7466):237-41 - PubMed
  65. Eur J Immunol. 2010 Jul;40(7):1830-5 - PubMed
  66. Clin Exp Immunol. 2009 Jul;157(1):104-18 - PubMed
  67. J Neuroimmune Pharmacol. 2011 Mar;6(1):148-57 - PubMed
  68. Exp Hematol. 2017 Jul;51:36-46 - PubMed
  69. PLoS One. 2012;7(8):e44219 - PubMed
  70. J Infect Dis. 2017 May 1;215(9):1386-1395 - PubMed
  71. Proc Natl Acad Sci U S A. 2009 Dec 22;106(51):21783-8 - PubMed
  72. J Immunol. 2004 Mar 1;172(5):2731-8 - PubMed
  73. Shock. 2014 Jun;41(6):463-75 - PubMed
  74. PLoS One. 2017 Jul 17;12(7):e0180377 - PubMed
  75. Nature. 1988 Sep 15;335(6187):256-9 - PubMed
  76. Blood. 2006 Jul 15;108(2):487-92 - PubMed
  77. Clin Immunol. 2010 Apr;135(1):84-98 - PubMed
  78. Exp Biol Med (Maywood). 2015 Jan;240(1):67-78 - PubMed
  79. Curr Top Microbiol Immunol. 2008;324:149-65 - PubMed
  80. J Virol. 2009 Jul;83(14):7305-21 - PubMed
  81. Virology. 2007 Dec 5;369(1):143-52 - PubMed
  82. Blood. 2011 Mar 17;117(11):3076-86 - PubMed
  83. Pathobiol Aging Age Relat Dis. 2011;1:null - PubMed
  84. J Vis Exp. 2014 Apr 01;(86):null - PubMed
  85. J Immunol. 2011 Jul 15;187(2):718-25 - PubMed
  86. J Immunol Methods. 2014 May;407:127-34 - PubMed

Publication Types

Grant support